Squarepoint’s Biodesix BDSX Stock Holding History

Squarepoint’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$354K	Buy	+15,709	New	+$233K	﹤0.01%	3691
2025 Q2	–	Sell	-7,092	Closed	-$88.7K	–	4491
2025 Q1	$88.7K	Buy	7,092 +6,416	+949%	+$123K	﹤0.01%	4250
2024 Q4	$20.7K	Buy	+676	New	+$19.9K	﹤0.01%	4933
2024 Q2	–	Sell	-682	Closed	-$19.5K	–	4060
2024 Q1	$19.5K	Buy	+682	New	+$23.3K	﹤0.01%	3929
2021 Q3	–	Sell	-1,750	Closed	-$462K	–	2917
2021 Q2	$462K	Sell	1,750 -488	-22%	-$153K	﹤0.01%	2190
2021 Q1	$909K	Sell	2,238 -1,868	-45%	-$834K	0.01%	1587
2020 Q4	$1.66M	Buy	+4,106	New	+$1.28M	0.01%	1037

Other funds holding BDSX

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Squarepoint's BDSX Position: Q2 2026 in Review

Squarepoint opened a new position in Biodesix (BDSX) in Q2 2026: 15,709 shares worth $354K. The stake represents ﹤0.01% of the portfolio and ranks #3691 among its holdings. This is a return to the name: Squarepoint previously reported a position in BDSX as recently as Q1 2025.

Squarepoint first reported a position in BDSX in Q4 2020 and has held it in 7 quarters since. The position peaked at $1.66M in Q4 2020. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

Squarepoint held 15,709 shares of Biodesix worth $354K as of Q2 2026.
Biodesix was a new Squarepoint position in Q2 2026.
Biodesix made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3691 holding.
Squarepoint first reported a position in Biodesix in Q4 2020 and has held it in 7 quarters since.
Squarepoint's Biodesix position peaked at $1.66M in Q4 2020.
45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.